Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL173057

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCOC(=O)C1=C(C)N=C(C)/C(=C(/O)OCC)C1c1c(C)noc1CCc1cccc(OC)c1

Basic Information

ChEMBL ID CHEMBL173057
Phase Preclinical
Structure Type MOL
InChI Key WPDNSRXMIZWUDL-YYDJUVGSSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

468.6
MW (Da)
4.98
ALogP
8
HBA
1
HBD
103.4
PSA (Ų)
0.41
QED
0
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H32N2O6
MW 468.55
Aromatic Rings 2
Heavy Atoms 34
NP-Likeness -0.80

Activity Summary

IC50 1 meas. best 5.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.8 5.8 1590.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 1590.0 nM 5.8 Inhibition of L-type calcium channel subunits alpha1C, beta1b, and alpha2-delta ... 12502362

Literature References

PubMed DOI Target Context # Activities
12502362 10.1021/jm020354w Unchecked 3

Data from ChEMBL 36 via Core Engine